TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bioconnect AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
7,599
|
6,517
|
6,118 |
| Financial expenses |
60
|
64
|
51 |
| Earnings before taxes |
18,815
|
1,560
|
988 |
| Total assets |
21,834
|
3,274
|
2,097 |
| Current assets |
21,365
|
2,941
|
1,697 |
| Current liabilities |
9,160
|
1,024
|
998 |
| Equity capital |
12,667
|
2,249
|
1,096 |
| - share capital |
66
|
71
|
75 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
58.0%
|
68.7%
|
52.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
247.6%
|
23.9%
|
16.1% |
| Return on assets (ROA) |
86.4%
|
49.6%
|
49.5% |
| Current ratio |
233.2%
|
287.2%
|
170.0% |
| Return on equity (ROE) |
148.5%
|
69.4%
|
90.1% |
| Change turnover |
1,483
|
721
|
-1,430 |
| Change turnover % |
24%
|
12%
|
-19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.